Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Atkins

Showing results (181-190 of 493) with videos related to

Pageof 50
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|April 13, 2011
Three-dimensional radiobiological dosimetry (3D-RD) with 124I PET for 131I therapy of thyroid cancerGeorge Sgouros, Robert F Hobbs, Francis B Atkins, et al.
BMC Cancer|October 19, 2017
Societal preferences for adjuvant melanoma health states: UK and AustraliaMark R Middleton, Michael B Atkins, Kaitlan Amos, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 2, 2007
Exploiting regulatory T-cell populations for the immunotherapy of cancerHans J J van der Vliet, Henry B Koon, Michael B Atkins, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 10, 2023
Multilevel cultural evolution: From new theory to practical applicationsDavid Sloan Wilson, Guru Madhavan, Michele J Gelfand, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2000
Phase I trial of twice-weekly intravenous interleukin 12 in patients with metastatic renal cell cancer or malignant melanoma: ability to maintain IFN-gamma induction is associated with clinical responseJ A Gollob, J W Mier, K Veenstra, et al.
The Journal of Clinical Endocrinology and Metabolism|October 13, 1998
Adrenarche results from development of a 3beta-hydroxysteroid dehydrogenase-deficient adrenal reticularisJ S Gell, B R Carr, H Sasano, et al.
The New England Journal of Medicine|June 16, 1988
Hypothyroidism after treatment with interleukin-2 and lymphokine-activated killer cellsM B Atkins, J W Mier, D R Parkinson, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|July 11, 2009
Refining indications for contemporary surgical treatment of renal cell carcinoma metastatic to the pancreasAram N Demirjian, Charles M Vollmer, David F McDermott, et al.
Developmental Dynamics : an Official Publication of the American Association of Anatomists|March 5, 2022
Normal development in Xenopus laevis: A complementary staging table for the skull based on cartilage and boneErin M MacKenzie, Jade B Atkins, Dana E Korneisel, et al.
Clinical Genitourinary Cancer|May 5, 2021
Time to Resolution of Axitinib-Related Adverse Events After Treatment Interruption in Patients With Advanced Renal Cell CarcinomaBrian I Rini, Michael B Atkins, Toni K Choueiri, et al.
Pageof 50

Showing results (181-190 of 493) with videos related to

Sort By:
Pageof 50
European Journal of Nuclear Medicine and Molecular Imaging|April 13, 2011
Three-dimensional radiobiological dosimetry (3D-RD) with 124I PET for 131I therapy of thyroid cancerGeorge Sgouros, Robert F Hobbs, Francis B Atkins, et al.
BMC Cancer|October 19, 2017
Societal preferences for adjuvant melanoma health states: UK and AustraliaMark R Middleton, Michael B Atkins, Kaitlan Amos, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 2, 2007
Exploiting regulatory T-cell populations for the immunotherapy of cancerHans J J van der Vliet, Henry B Koon, Michael B Atkins, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 10, 2023
Multilevel cultural evolution: From new theory to practical applicationsDavid Sloan Wilson, Guru Madhavan, Michele J Gelfand, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2000
Phase I trial of twice-weekly intravenous interleukin 12 in patients with metastatic renal cell cancer or malignant melanoma: ability to maintain IFN-gamma induction is associated with clinical responseJ A Gollob, J W Mier, K Veenstra, et al.
The Journal of Clinical Endocrinology and Metabolism|October 13, 1998
Adrenarche results from development of a 3beta-hydroxysteroid dehydrogenase-deficient adrenal reticularisJ S Gell, B R Carr, H Sasano, et al.
The New England Journal of Medicine|June 16, 1988
Hypothyroidism after treatment with interleukin-2 and lymphokine-activated killer cellsM B Atkins, J W Mier, D R Parkinson, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|July 11, 2009
Refining indications for contemporary surgical treatment of renal cell carcinoma metastatic to the pancreasAram N Demirjian, Charles M Vollmer, David F McDermott, et al.
Developmental Dynamics : an Official Publication of the American Association of Anatomists|March 5, 2022
Normal development in Xenopus laevis: A complementary staging table for the skull based on cartilage and boneErin M MacKenzie, Jade B Atkins, Dana E Korneisel, et al.
Clinical Genitourinary Cancer|May 5, 2021
Time to Resolution of Axitinib-Related Adverse Events After Treatment Interruption in Patients With Advanced Renal Cell CarcinomaBrian I Rini, Michael B Atkins, Toni K Choueiri, et al.
Pageof 50